• PDF: usually within 24 hours UK time

Alzheimer's Disease: Lifecycle Pharma Forecast, 2012-2035 – Europe

  • Publication Date:February 2012
  • Publisher:SlideScript
  • Product Type: Report
  • Pages:60

Alzheimer's Disease: Lifecycle Pharma Forecast, 2012-2035 – Europe

SlideScript's Lifecycle Pharma Forecast reports deliver essential therapy area benchmarking data and quantitative market estimates projected across multiple regions and individual countries. Data-rich tables enable rapid understanding of market values, product revenue potential and pricing comparisons over a patentable 20-year period.

Insights and projections facilitate, aid, and validate commercial activities related to pricing and reimbursement, market access, health economics modelling, business development, or licensing.

Benefits of this publication include:

  • Country-specific epidemiology: prevalence and disease populations
  • Retail pricing indices across regions and countries
  • Market forecasts to 2035
  • Price-point forecasts to 2035
  • Leading product revenues to 2012
  • Comparative value-based disease market outlook by region
  • Insight into market dynamics across countries
  • Summative market values across territories and age groups
  • Treatment stratification effects on pricing
  • Revenue projections based on dosing regimens

This report is essential to:

  • Support corporate strategy and planning
  • Determine or explore pricing models, health economics, pricing and reimbursement
  • Validate proprietary data, key assumptions, introducing to target markets
  • Evaluate national/regional pricing strengths and weaknesses
  • Benchmark data against market thresholds
  • i. About SlideScript Pharma
  • 1. FRANCE
  • 2. GERMANY
  • 3. ITALY
  • 4. SPAIN
  • 5. UNITED KINGDOM
  • 6. DENMARK
  • 7. PORTUGAL
  • 8. NORWAY
  • 9. SWEDEN
  • List of Tables
    • 1. FRANCE
      • Table 1. Alzheimer's Disease: France - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 2. Alzheimer's Disease: France - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 3. Alzheimer's Disease: France - Market Forecast (Euros €), 2012-2035
      • Table 4. Alzheimer's Disease: France - Product Revenue Forecast (Euros €) 2012-2035
      • Table 5. Alzheimer's Disease: France - Product Revenue Forecast (Euros €) 2012-2035
      • Table 6. Alzheimer's Disease: France - Product Revenue Forecast (Euros €) 2012-2035
    • 2. GERMANY
      • Table 7. Alzheimer's Disease: Germany - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 8. Alzheimer's Disease: Germany - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 9. Alzheimer's Disease: Germany - Market Forecast (Euros €), 2012-2035
      • Table 10. Alzheimer's Disease: Germany - Product Revenue Forecast (Euros €) 2012-2035
      • Table 11. Alzheimer's Disease: Germany - Product Revenue Forecast (Euros €) 2012-2035
      • Table 12. Alzheimer's Disease: Germany - Product Revenue Forecast (Euros €) 2012-2035
    • 3. ITALY
      • Table 13. Alzheimer's Disease: Italy - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 14. Alzheimer's Disease: Italy - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 15. Alzheimer's Disease: Italy - Market Forecast (Euros €), 2012-2035
      • Table 16. Alzheimer's Disease: Italy - Product Revenue Forecast (Euros €) 2012-2035
      • Table 17. Alzheimer's Disease: Italy - Product Revenue Forecast (Euros €) 2012-2035
      • Table 18. Alzheimer's Disease: Italy - Product Revenue Forecast (Euros €) 2012-2035
    • 4. SPAIN
      • Table 19. Alzheimer's Disease: Spain - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 20. Alzheimer's Disease: Spain - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 21. Alzheimer's Disease: Spain - Market Forecast (Euros €), 2012-2035
      • Table 22. Alzheimer's Disease: Spain - Product Revenue Forecast (Euros €) 2012-2035
      • Table 23. Alzheimer's Disease: Spain - Product Revenue Forecast (Euros €) 2012-2035
      • Table 24. Alzheimer's Disease: Spain - Product Revenue Forecast (Euros €) 2012-2035
    • 5. UNITED KINGDOM
      • Table 25. Alzheimer's Disease: UK - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 26. Alzheimer's Disease: UK - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 27. Alzheimer's Disease: UK - Market Forecast (Euros €), 2012-2035
      • Table 28. Alzheimer's Disease: UK - Product Revenue Forecast (Euros €) 2012-2035
      • Table 29. Alzheimer's Disease: UK - Product Revenue Forecast (Euros €) 2012-2035
      • Table 30. Alzheimer's Disease: UK - Product Revenue Forecast (Euros €) 2012-2035
    • 6. DENMARK
      • Table 31. Alzheimer's Disease: Denmark - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 32. Alzheimer's Disease: Denmark - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 33. Alzheimer's Disease: Denmark - Market Forecast (Euros €), 2012-2035
      • Table 34. Alzheimer's Disease: Denmark - Product Revenue Forecast (Euros €) 2012-2035
      • Table 35. Alzheimer's Disease: Denmark - Product Revenue Forecast (Euros €) 2012-2035
      • Table 36. Alzheimer's Disease: Denmark - Product Revenue Forecast (Euros €) 2012-2035
    • 7. PORTUGAL
      • Table 37. Alzheimer's Disease: Portugal - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 38. Alzheimer's Disease: Portugal - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 39. Alzheimer's Disease: Portugal - Market Forecast (Euros €), 2012-2035
      • Table 40. Alzheimer's Disease: Portugal - Product Revenue Forecast (Euros €) 2012-2035
      • Table 41. Alzheimer's Disease: Portugal - Product Revenue Forecast (Euros €) 2012-2035
      • Table 42. Alzheimer's Disease: Portugal - Product Revenue Forecast (Euros €) 2012-2035
    • 8. NORWAY
      • Table 43. Alzheimer's Disease: Norway - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 44. Alzheimer's Disease: Norway - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 45. Alzheimer's Disease: Norway - Market Forecast (Euros €), 2012-2035
      • Table 46. Alzheimer's Disease: Norway - Product Revenue Forecast (Euros €) 2012-2035
      • Table 47. Alzheimer's Disease: Norway - Product Revenue Forecast (Euros €) 2012-2035
      • Table 48. Alzheimer's Disease: Norway - Product Revenue Forecast (Euros €) 2012-2035
    • 9. SWEDEN
      • Table 49. Alzheimer's Disease: Sweden - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
      • Table 50. Alzheimer's Disease: Sweden - Treatment Stratification and Market Forecast (Euros €), 2012-2019
      • Table 51. Alzheimer's Disease: Sweden - Market Forecast (Euros €), 2012-2035
      • Table 52. Alzheimer's Disease: Sweden - Product Revenue Forecast (Euros €) 2012-2035
      • Table 53. Alzheimer's Disease: Sweden - Product Revenue Forecast (Euros €) 2012-2035
      • Table 54. Alzheimer's Disease: Sweden - Product Revenue Forecast (Euros €) 2012-2035
+44 20 8816 8548

Ask a question about Alzheimer's Disease: Lifecycle Pharma Forecast, 2012-2035 – Europe

Enter the characters you see in the picture below
Captcha